Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

McIntyre Partnerships 2026 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (McIntyre Partnerships)

Primary Source Intelligence • Q2 2026 Letter Analysis

McIntyre Partnerships Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, McIntyre Partnerships. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+23.3%

YTD-1.2%

Annualized+9.9%

Positioning StanceConstructive

Market CapSmallCap

Digest Analysis

Quick Take

"The manager maintains extreme concentration with five positions representing 88% of assets, viewing QDEL as a once-in-a-decade opportunity."

Executive Summary

McIntyre Partnerships delivered a strong Q2 2026 with 23.3% net returns, fully reversing Q1 losses but remaining flat year-to-date at -1.2% net. The portfolio experienced a broad-based rally across almost all holdings, driven by positive idiosyncratic events rather than just market momentum. The most significant development was news that QDEL is in late stages of divesting its Point of Care business for approximately $1.5B at 10x EV/EBITDA, which would deleverage the company and enable share repurchases. The manager views QDEL as a once-in-five-to-ten-year opportunity and maintains it as the largest position. Other major holdings showed strong progress: SHC's Sterigenics segment returned to high single-digit growth with favorable legal developments, while STHO made significant progress unwinding legacy real estate holdings and its SAFE investment rallied 20%. The CRO market inflection from biotech M&A benefited FTRE and signals positive momentum for life science tools broadly. The highly concentrated portfolio (five positions representing 88% of assets) reflects the manager's high conviction in these multibagger opportunities. The fund plans to reopen in H1 2027 after being closed since Q1 2025.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

88%

CautiousHigh

High Conviction (88%)

The manager demonstrates extreme conviction through portfolio construction and explicit statements. Five positions represent 88% of assets, with QDEL described as a significantly concentrated position and a once-in-five-to-ten-year opportunity that he plans to retain for the foreseeable future. He provides specific price targets (QDEL at $100/share, SHC doubling from current price, STHO at $24.50 NAV versus $9.37 price) and detailed fundamental analysis including cap rate comparisons, EBITDA multiples, and balance sheet breakdowns. The language is declarative rather than hedged, and he explicitly states high conviction in the portfolio despite YTD underperformance. This level of concentration, specificity, and willingness to maintain positions through volatility warrants a score in the 0.85-0.89 range.

Growth Outlook

50%

BearishBullish

Neutral (50%)

The manager expresses constructive views on specific market segments, particularly the CRO market inflection from biotech M&A and fundraising in 2025, which he views as a positive early sign for life science tools. He notes the sharp rally in the overall market helped portfolio performance. However, there is no broad market commentary beyond these sector-specific observations. The tone is selectively positive on specific opportunities rather than making broad market calls.

Risk Appetite

75%

DefensiveAggressive

Aggressive (75%)

The portfolio is aggressively positioned with 116% long exposure, 26% short, and 90% net exposure. The manager maintains extreme concentration with five positions representing 88% of assets, with QDEL described as a significantly concentrated position. This represents a clear risk-on posture with high conviction in specific names rather than defensive positioning.

Capital Deployment

0%

De-riskingDeploying

De-risking (0%)

The letter provides no information about changes in cash levels during the quarter. While the manager discusses maintaining positions and expresses high conviction, there is no evidence of net deployment or de-risking. The fund has been closed to new capital since Q1 2025 and plans to reopen in H1 2027, suggesting no new capital is being deployed. Gross and net exposures are stated (116% long, 90% net) but without prior period comparisons. The discussion focuses on existing positions rather than additions or reductions. Without cash level data or explicit deployment activity, the score defaults to 0.00.

Forward Guidance

60%

CautiousExpansionary

Neutral (60%)

The manager explicitly states plans to retain a significant investment in QDEL for the foreseeable future and describes several large investments as multibagger opportunities with strong catalysts. He expresses high conviction in the portfolio despite flat YTD results. The fund plans to reopen in H1 2027, suggesting confidence in deploying additional capital. However, there is no explicit discussion of adding new positions or scaling existing ones in the near term.

Language Signal

65%

BearishBullish

Bullish (65%)

The letter is dominated by opportunity-focused language: once-in-five-to-ten-year opportunity, multibagger opportunities, strong catalysts, positive idiosyncratic events, broad-based rally, high conviction, substantial upside. Risk language is minimal and mostly confined to acknowledging volatility and specific operational challenges (Chinese regulations, litigation). The balance clearly tilts toward bullish directional language on the portfolio holdings.

Perceived Risk

25%

Low RiskElevated

Low Risk (25%)

The manager acknowledges some specific risks but does not dwell on them or frame them as material threats. He mentions QDEL's repeated missed estimates, Chinese regulatory headwinds (expected to resolve in coming months), SHC litigation (with favorable recent developments), and volatility in achieving flat first half results. However, these risks are immediately contextualized as manageable or resolving. There is no discussion of systemic risks, market-level concerns, or tail scenarios. The tone is confident rather than cautious, with risks mentioned as part of the investment narrative rather than as central concerns.

Opportunity Density

70%

ScarceAbundant

Abundant (70%)

The manager describes several large investments with strong catalysts as multibagger opportunities and characterizes QDEL as a once-in-five-to-ten-year opportunity. He identifies specific catalysts across multiple holdings (QDEL asset sale, SHC litigation resolution and PE overhang removal, STHO real estate liquidation and capital returns, SAFE valuation gap closure). The CRO market inflection is viewed as benefiting multiple holdings. While the portfolio is highly concentrated, the manager clearly sees abundant opportunity within his existing positions and expresses high conviction in their upside potential. This suggests a selective but rich opportunity set within his defined universe.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The manager explicitly states plans to retain a significant QDEL investment for the foreseeable future and describes it as a once-in-five-to-ten-year opportunity, indicating a multi-year horizon. However, the letter also focuses heavily on near-term catalysts: QDEL asset sale in late stages, Chinese regulations finalizing in coming months, STHO capital returns as soon as fall 2026, complete real estate exit by end of 2027. The manager provides specific 2028 and 2029 earnings estimates for holdings, suggesting a 2-4 year value realization timeframe. This combination of multi-year holding intent with 1-3 year catalyst dependency places the time horizon in the 0.65-0.74 range.